{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:50:05Z","timestamp":1772308205883,"version":"3.50.1"},"reference-count":35,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Computational and Mathematical Methods in Medicine"],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:p>Objective. A case-control study was adopted to investigate the efficacy and side effects of irinotecan combined with nedaplatin (NP) versus paclitaxel combined with cisplatin for locally advanced cervical cancer (CC) neoadjuvant chemotherapy (NACT) and to analyze the changes in tumor marker levels. Methods. A total of 96 patients with locally advanced CC who were treated from October 2019 to October 2021 were enrolled in our hospital as the research subjects, and their clinical data were collected for retrospective analysis and grouped according to their treatment regimens. Among them, 53 patients received paclitaxel combined with cisplatin as the control group, and the other 43 patients received irinotecan combined with NP as the observation group. The clinical effectiveness of neoadjuvant chemotherapy and alterations in tumor markers (CEA, AFP, CA125, and SCCA) were compared between the two groups. The incidence of common chemotherapy side effects was observed and compared between the two groups, including nausea and vomiting, abdominal pain and diarrhea, liver function impairment, bone marrow suppression, transient hyperglycemia, rash, ECG abnormalities, peripheral neurotoxicity, and muscle aches and pains. Results. The clinical efficiency of neoadjuvant chemotherapy was 97.67% in the observation group and 81.13% in the control group, with no statistically significant difference between the groups (<jats:inline-formula>\n                     <a:math xmlns:a=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M1\">\n                        <a:mi>P<\/a:mi>\n                        <a:mo>&gt;<\/a:mo>\n                        <a:mn>0.05<\/a:mn>\n                     <\/a:math>\n                  <\/jats:inline-formula>). There was no significant difference in CEA, AFP, and CA125 between the two groups before and after chemotherapy, but the decrease of SCCA before and after chemotherapy was statistically significant. There was no significant difference in the incidence of liver function damage, myelosuppression, abnormal ECG, and rash between the two groups (<jats:inline-formula>\n                     <c:math xmlns:c=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M2\">\n                        <c:mi>P<\/c:mi>\n                        <c:mo>&gt;<\/c:mo>\n                        <c:mn>0.05<\/c:mn>\n                     <\/c:math>\n                  <\/jats:inline-formula>). There are statistically significant differences in the incidence of nausea and vomiting, transient hyperglycemia, peripheral neurotoxicity, and muscle aches between the observation and control groups (<jats:inline-formula>\n                     <e:math xmlns:e=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M3\">\n                        <e:mi>P<\/e:mi>\n                        <e:mo>&lt;<\/e:mo>\n                        <e:mn>0.05<\/e:mn>\n                     <\/e:math>\n                  <\/jats:inline-formula>). The incidence of nausea and vomiting, transient hyperglycemia, peripheral neurotoxicity, and muscle aches was higher in the control group than in the observation group, with statistically significant differences (<jats:inline-formula>\n                     <g:math xmlns:g=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M4\">\n                        <g:mi>P<\/g:mi>\n                        <g:mo>&lt;<\/g:mo>\n                        <g:mn>0.05<\/g:mn>\n                     <\/g:math>\n                  <\/jats:inline-formula>). The difference in the incidence of diarrhea and abdominal pain between the observation group and the control group was statistically significant (<jats:inline-formula>\n                     <i:math xmlns:i=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" id=\"M5\">\n                        <i:mi>P<\/i:mi>\n                        <i:mo>&lt;<\/i:mo>\n                        <i:mn>0.05<\/i:mn>\n                     <\/i:math>\n                  <\/jats:inline-formula>), and the incidence of diarrhea and abdominal pain in the observation group was higher than that in the control group. Conclusion. Irinotecan in combination with nedaplatin can be an effective neoadjuvant chemotherapy regimen for advanced localized cervical cancer, particularly in patients with combined diabetes.<\/jats:p>","DOI":"10.1155\/2022\/5936773","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T20:50:10Z","timestamp":1654116610000},"page":"1-8","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis"],"prefix":"10.1155","volume":"2022","author":[{"given":"Yu","family":"Jiang","sequence":"first","affiliation":[{"name":"Provincial Clinical College of Fujian Medical University (Department of Gynecology, Fujian Provincial Hospital), Fuzhou, 350001 Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baozhi","family":"Song","sequence":"additional","affiliation":[{"name":"Provincial Clinical College of Fujian Medical University (Department of Gynecology, Fujian Provincial Hospital), Fuzhou, 350001 Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-6531","authenticated-orcid":true,"given":"Zhiqin","family":"Chen","sequence":"additional","affiliation":[{"name":"Provincial Clinical College of Fujian Medical University (Department of Gynecology, Fujian Provincial Hospital), Fuzhou, 350001 Fujian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32470-X"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2018.06.003"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30667"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30482-6"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19821115)50:10<1979::AID-CNCR2820501002>3.0.CO;2-D"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2016.00257"},{"issue":"8","key":"7","first-page":"103","article-title":"Comparative analysis of the efficacy of NACT and simple surgery in patients with locally advanced CC. Electronic Journal of practical","volume":"6","author":"S. You","year":"2019","journal-title":"Gynecological Endocrinology"},{"issue":"27","key":"8","first-page":"51","article-title":"Evaluation of short-term effect and long-term survival rate of NACT and simple operation in patients with stage I B2 and II A2 CC","volume":"56","author":"H. Ping","year":"2018","journal-title":"Modern Chinese Doctors"},{"issue":"9","key":"9","first-page":"45","article-title":"Effect of thoracoscopic surgery after NACT on serum CYFRA21-1 and NSE in patients with stage III a-N2 NSCLC","volume":"46","author":"Z. Fang","year":"2018","journal-title":"Modern Medicine"},{"issue":"1","key":"10","first-page":"42","article-title":"Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology Institute\" Prof. Dr. Ion Chiricuta\" experience","volume":"11","author":"A. Marita","year":"2018","journal-title":"Journal of Medicine & Life"},{"issue":"8","key":"11","first-page":"76","article-title":"Observation on the efficacy of arterial interventional NACT in patients with locally advanced CC","volume":"51","author":"S. Xuesong","year":"2016","journal-title":"Chinese Medical Journals"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1038\/nature21386"},{"issue":"14","key":"13","first-page":"181","article-title":"Study on the efficacy of paclitaxel in the treatment of cervical and endometrial carcinoma","volume":"9","author":"Y. G. Liu","year":"2017","journal-title":"Continuing Medical Education in China"},{"issue":"14","key":"14","first-page":"17","article-title":"Effect of cetuximab combined with paclitaxel+ cisplatin NACT on esophageal cancer cell proliferation and invasion","volume":"23","author":"Y. L. Zhao","year":"2017","journal-title":"Journal of Hainan Medical University (English version)"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201804882"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v12.i5.323"},{"issue":"10","key":"17","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.2147\/OTT.S145934","article-title":"Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer","volume":"23","author":"L. Huang","year":"2017","journal-title":"Onco Targets and Therapy"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.4103\/apjon.apjon_73_18"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_39_18"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14485"},{"issue":"10","key":"21","first-page":"16","article-title":"The incidence trend and countermeasures of CC getting younger","volume":"8","author":"W. Jiejie","year":"2017","journal-title":"Journal of traditional Chinese Medicine Management"},{"issue":"12","key":"22","first-page":"952","article-title":"Effect of NACT on overall treatment strategy in patients with operable breast cancer","volume":"39","author":"Z. Wenshu","year":"2017","journal-title":"Chinese Journal of Oncology"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.26911\/theijmed.2018.03.02.08"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.8.1740"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.101945"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7203758"},{"issue":"11","key":"27","first-page":"1185","article-title":"The problems and countermeasures of preoperative chemotherapy for CC from the real-world clinical study of big data in China","volume":"34","author":"C. Chunlin","year":"2018","journal-title":"Chinese Journal of practical Gynecology and Obstetrics"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.011.10050"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8020156"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2016.04.038"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001357"},{"issue":"11","key":"32","first-page":"1203","article-title":"Selection of preoperative chemotherapy drugs and regimens for locally advanced CC","volume":"34","author":"Z. Shiqian","year":"2018","journal-title":"Chinese Journal of practical Gynecology and Obstetrics"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000010913"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3742-1"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3284"}],"updated-by":[{"DOI":"10.1155\/2023\/9869683","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"record-id":"47493"},{"DOI":"10.1155\/2023\/9869683","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000}}],"container-title":["Computational and Mathematical Methods in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/5936773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/5936773.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/cmmm\/2022\/5936773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T20:50:25Z","timestamp":1654116625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/cmmm\/2022\/5936773\/"}},"subtitle":[],"editor":[{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":35,"alternative-id":["5936773","5936773"],"URL":"https:\/\/doi.org\/10.1155\/2022\/5936773","relation":{"retraction":[{"id-type":"doi","id":"10.1155\/2023\/9869683","asserted-by":"object"}]},"ISSN":["1748-6718","1748-670X"],"issn-type":[{"value":"1748-6718","type":"electronic"},{"value":"1748-670X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}